BT4C cells (0.01 x 10E6 cells) then gene transfer of the 15-LO-1 gene using an adenovirus vector (5 ul) then gene transfer of the 15-LO-1 gene using an adenovirus vector (7.5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
BT4C cells (0.01 x 10E6 cells) then gene transfer of the HSV-tk gene using an adenovirus vector (10 ul) then gene transfer of the HSV-tk gene using an adenovirus vector (5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
BT4C cells (0.01 x 10E6 cells) then gene transfer of the HSV-tk gene using an adenovirus vector (10 ul) and gene transfer of the 15-LO-1 gene using an adenovirus vector (5 ul) then gene transfer of the HSV-tk gene using an adenovirus vector (5 ul) and gene transfer of the 15-LO-1 gene using an adenovirus vector (7.5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
Table "column sort" updates the order of the bars in the chart.
BT4C cells (0.01 x 10E6 cells) then gene transfer of the HSV-tk gene using an adenovirus vector (10 ul) and gene transfer of the 15-LO-1 gene using an adenovirus vector (5 ul) then gene transfer of the HSV-tk gene using an adenovirus vector (5 ul) and gene transfer of the 15-LO-1 gene using an adenovirus vector (7.5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
Pacholska A, etal., Cancer Gene Ther. 2012 Dec;19(12):870-4. doi: 10.1038/cgt.2012.76. Epub 2012 Oct 19.
BT4C cells (0.01 x 10E6 cells) then gene transfer of the HSV-tk gene using an adenovirus vector (10 ul) then gene transfer of the HSV-tk gene using an adenovirus vector (5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
Pacholska A, etal., Cancer Gene Ther. 2012 Dec;19(12):870-4. doi: 10.1038/cgt.2012.76. Epub 2012 Oct 19.
BT4C cells (0.01 x 10E6 cells) then gene transfer of the 15-LO-1 gene using an adenovirus vector (5 ul) then gene transfer of the 15-LO-1 gene using an adenovirus vector (7.5 ul) then ganciclovir (50 mg/kg/d) (for 14 days)
Pacholska A, etal., Cancer Gene Ther. 2012 Dec;19(12):870-4. doi: 10.1038/cgt.2012.76. Epub 2012 Oct 19.